ENTBF (Entheon Biomedical) OCF Margin %: 0.00% (As of Feb. 2026)


What is Entheon Biomedical OCF Margin %?

Entheon Biomedical ENTBF OCF Margin % is 0.00% as of Feb. 2026. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, Entheon Biomedical ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Entheon Biomedical's Cash Flow from Operations for the three months ended in Feb. 2026 was $-0.04 Mil. Entheon Biomedical's Revenue for the three months ended in Feb. 2026 was $0.00 Mil. Therefore, Entheon Biomedical's OCF Margin % for the quarter that ended in Feb. 2026 was 0.00%.

As of today, Entheon Biomedical's current OCF Yield % is -37.09%.

The historical rank and industry rank for Entheon Biomedical's OCF Margin % or its related term are showing as below:


During the past 9 years, the highest OCF Margin % of Entheon Biomedical was -144.00%. The lowest was -1028.95%. And the median was -586.48%.

ENTBF's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Entheon Biomedical OCF Margin % Related Terms

Entheon Biomedical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical OCF Margin % Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23 Nov24 Nov25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 -1,030.50 -144.51 0.00 0.00

Entheon Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Entheon Biomedical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Entheon Biomedical's OCF Margin for the fiscal year that ended in Nov. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Nov. 2025 )/Revenue (A: Nov. 2025 )
=-0.224/0
= %

Entheon Biomedical's OCF Margin for the quarter that ended in Feb. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-0.04/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Entheon Biomedical (ENTBF) has a OCF Margin % of 0.00% as of Feb. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Entheon Biomedical and its competitors. According to the industry distribution chart, Entheon Biomedical ranks #999999 out of 959 companies in the Biotechnology industry.
Is Entheon Biomedical's OCF Margin % too high?
Entheon Biomedical's current OCF Margin % is 0.00%. Based on the distribution chart, Entheon Biomedical ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Entheon Biomedical's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Entheon Biomedical ranks #999999 out of 959 companies for OCF Margin %. This places Entheon Biomedical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Entheon Biomedical and its competitors. Entheon Biomedical's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current OCF Margin % is 0.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges 1XU:GermanyENBI.X:Canada
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.